Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Extravasation of Diagnostic and Therapeutic Materials”

27 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 27 results

Testing effectiveness (Phase 2)Study completedNCT00333736
What this trial is testing

Study to Assess Safety and Quality of Life of Patients Using Biojector Versus Needles for Fuzeon Administration

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 337
Not applicableUnknownNCT05221333
What this trial is testing

Sorrel 25R Injector - Sorrel Clinical Study Protocol

Who this might be right for
Injection SiteInjection Site ReactionInjection Site Irritation
Eitan Medical 20
Not applicableStudy completedNCT01126710
What this trial is testing

Optical Detection of Intravenous Infiltration

Who this might be right for
Intravenous InfiltrationExtravasation of Diagnostic and Therapeutic Materials
CW Optics, Inc. 263
Not applicableStudy completedNCT03645369
What this trial is testing

Effectiveness of Mechano-Analgesia and Cold Application on Ecchymosis, Pain and Satisfaction at Subcutaneous Heparin Injection

Who this might be right for
Injection Site ReactionInjection Site Bruising
Istanbul Saglik Bilimleri University 165
Post-approval studies (Phase 4)Study completedNCT05028361
What this trial is testing

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

Who this might be right for
Quality of LifeInjection Site ReactionAdverse Drug Event+1 more
Duke University 348
Not applicableEnded earlyNCT02434055
What this trial is testing

Evaluation of a Novel Method of Contrast Volume Quantification - AVERT PLUS

Who this might be right for
Extravasation of Contrast Media
Anand Prasad 10
Not applicableStudy completedNCT01271608
What this trial is testing

Study to Evaluate the Need of Needle Change for Application of Intramuscular, Subcutaneous and Intradermal Injection.

Who this might be right for
Knowledge, Attitudes, PracticeInjection Site Reactions
Hospital M'Boi Mirim 1,240
Post-approval studies (Phase 4)Study completedNCT03841396
What this trial is testing

A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers.

Who this might be right for
Injection Site Reaction
Aspen Global Incorporated 15
Testing effectiveness (Phase 2)Study completedNCT03963115
What this trial is testing

Can Epinephrine Coated Syringe for Subcutaneous Immunotherapy (SCIT) Reduce Large Local Reaction?

Who this might be right for
Injection Reactions SiteSystemic Reactions
Mahidol University 17
Not applicableStudy completedNCT06093815
What this trial is testing

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Who this might be right for
Injection Site Reaction
Merz North America, Inc. 20
Early research (Phase 1)Study completedNCT00365781
What this trial is testing

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 10
Post-approval studies (Phase 4)UnknownNCT04962152
What this trial is testing

Naldebain and Video-assisted Thoracoscopic Surgery

Who this might be right for
AnalgesiaNausea and Vomiting, PostoperativeItching+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Post-approval studies (Phase 4)WithdrawnNCT02568111
What this trial is testing

Brimonidine Tartrate for the Treatment of Injection Related Erythema

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Biogen
Not applicableStudy completedNCT05157191
What this trial is testing

Safety of Pediatric COVID-19 Vaccination

Who this might be right for
PainInjection Site ReactionAdverse Drug Event
Duke University 299
Not applicableUnknownNCT06032819
What this trial is testing

Differentiating Between Brain Hemorrhage and Contrast

Who this might be right for
Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 500
Not applicableStudy completedNCT02580760
What this trial is testing

Transgender, Silicone and Blood Smear

Who this might be right for
Injection; Complications, SepsisInjection Site DisorderInjection Site Extravasation+1 more
Assistance Publique - Hôpitaux de Paris 66
Not applicableStudy completedNCT03347370
What this trial is testing

A Post-Authorization Safety Study of Interferon Beta Therapy in Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 626
Post-approval studies (Phase 4)UnknownNCT03424733
What this trial is testing

Evaluating the Use of Prednisone to Decrease Pegylated Interferon Beta-1a Side Effects

Who this might be right for
Multiple Sclerosis
Holy Name Medical Center, Inc. 50
Not applicableUnknownNCT05675774
What this trial is testing

DECT for Differentiating Intracerebral Hemorrhage From Contrast Extravasation

Who this might be right for
Stroke, IschemicTomography, X-Ray Computed
University of Manitoba 200
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Load More Results